PUBLICATIONS · 22453568
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- JAMA
- Publication date
- 2012 Mar 28
- First author
- Joensuu H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- JAMA. 2012 Mar 28;307(12):1312-4. doi: 10.1001/jama.2012.368.
- note
- Source null
- related pmid
- 22453573
- relationship
- Comment in
Authors and identifiers
- name
- Joensuu H
- type
- Author
- name
- Eriksson M
- type
- Author
- name
- Sundby Hall K
- type
- Author
- name
- Hartmann JT
- type
- Author
- name
- Pink D
- type
- Author
- name
- Schütte J
- type
- Author
- name
- Ramadori G
- type
- Author
- name
- Hohenberger P
- type
- Author
- name
- Duyster J
- type
- Author
- name
- Al-Batran SE
- type
- Author
- name
- Schlemmer M
- type
- Author
- name
- Bauer S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Joensuu H
- type
- Author
- name
- Eriksson M
- type
- Author
- name
- Sundby Hall K
- type
- Author
- name
- Hartmann JT
- type
- Author
- name
- Pink D
- type
- Author
- name
- Schütte J
- type
- Author
- name
- Ramadori G
- type
- Author
- name
- Hohenberger P
- type
- Author
- name
- Duyster J
- type
- Author
- name
- Al-Batran SE
- type
- Author
- name
- Schlemmer M
- type
- Author
- name
- Bauer S
- type
- Author
- bibliography ids
- nci-bib-0d50a77e6fe6d2a0c02faef9
- book metadata
- content sha256
- ad89ab70d22f3d20afc07b4747c2b4bb336fef81bf885e429380920370efa335
- document type
- citation
- dois
- 10.1001/jama.2012.347
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22453568
- immutable id
- pubmed:22453568@ad89ab70d22f3d20afc07b4747c2b4bb336fef81bf885e429380920370efa335
- journal
- abbreviation
- JAMA
- issn electronic
- 1538-3598
- issn print
- 0098-7484
- issue
- 12
- name
- JAMA
- nlm unique id
- 7501160
- pages
- 1265-72
- volume
- 307
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- JAMA. 2012 Mar 28;307(12):1312-4. doi: 10.1001/jama.2012.368.
- note
- Source null
- related pmid
- 22453573
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 22453568
- provenance
- batch id
- c95be1d0b8cf19942816
- provider
- NCBI PubMed ESummary
- record sha256
- 7137f333ffe359407454219ef61dc2cc143981d177ee5c24a0d3b4db6da85342
- response sha256
- a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
- retrieved at
- 2026-09-09T23:46:47.691937+00:00
- publication date
- display
- 2012 Mar 28
- precision
- day
- year
- 2012
- publication types
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
Preserved source evidence · Not medical advice
Triangle